| | | |   | | | | By Ed Silverman Eugene Hoshiko/AP In a letter to the Pfizer CEO, U.S. Sen. Elizabeth Warren (D-Mass) and Sen. Peter Welch (D-Vt) called the price hike "pure and deadly greed." Read More | | By Jason Mast KAZUHIRO NOGI/AFP via Getty Images The drug could offer a new way to tamp down the inflammation that contributes to various autoimmune diseases. Read More | | By Matthew Herper Ruby Wallau for STAT New data offers the first evidence of an effective individualized cancer vaccine based on mRNA, the technology used in the Covid shots. Read More | | Sponsored Insight by STAT TRIALS PULSE Could warning signs in Summit Therapeutics' clinical trial activity have hinted at bad results months before they were announced? There are an average of over 6,800 clinical trials updates every day. Trying to analyze these changes and identify patterns is a staggering but essential undertaking for life sciences professionals seeking competitive intelligence. That's where STAT Trials Pulse steps in. We connect disparate sources of clinical trials data, detect important updates, and add context to deliver a curated stream of actionable alerts. Learn more at statnews.com/trials-pulse, or start your 30-day free trial.
| | By Angus Chen Ed Uthman/Creative Commons The standard was a “dirty inhibitor,” which inhibited both a cancer-linked protein and others. Now there's a more effective drug available. Read More | |
No comments